Revision history of "GENERIC NON-SEDATING AND LONG-ACTING HISTAMINE ANTAGONIST DRUG FOR THE TREATMENT OF ALLERGIC RHINOCONJUNCTIVITIS AND HIVES." (Q3189865)

11 October 2024

• curprev 09:4909:49, 11 October 2024‎ DG Regio talk contribs‎ 83,129 bytes −24‎ ‎Changed label, description and/or aliases in pt
• curprev 09:4909:49, 11 October 2024‎ DG Regio talk contribs‎ 83,153 bytes −17‎ ‎Set a claim value: summary (P836): Este projeto visa dar continuidade à política de desenvolvimento de medicamentos genéricos destinados ao tratamento de patologias com elevado impacto socioeconómico, e propõe o desenvolvimento de uma nova especialidade genérica de bilastina, comprimidos de 20 mg, para o tratamento da rinoconjuntivite alérgica e colmeias._x000D_ Atualmente não está registada bilastina genérica no mercado espanhol e o desenvolvimento previsto deve demonstrar a sua bio...

7 March 2024

• curprev 11:1011:10, 7 March 2024‎ DG Regio talk contribs‎ 83,170 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.6344492987434829

20 December 2023

• curprev 17:3617:36, 20 December 2023‎ DG Regio talk contribs‎ 82,882 bytes −113‎ ‎Changed an Item

12 June 2023

• curprev 14:4314:43, 12 June 2023‎ DG Regio talk contribs‎ 82,995 bytes +1,742‎ ‎Changed an Item

10 June 2023

• curprev 07:0407:04, 10 June 2023‎ Admin talk contribs‎ 81,253 bytes +437‎ BatchIngestion

18 August 2022

• curprev 07:1107:11, 18 August 2022‎ DG Regio talk contribs‎ 80,816 bytes +55,566‎ ‎Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

• curprev 15:4615:46, 16 January 2022‎ DG Regio talk contribs‎ 25,250 bytes +2,905‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

17 December 2021

• curprev 17:4417:44, 17 December 2021‎ DG Regio talk contribs‎ 22,345 bytes +3,007‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

9 December 2021

• curprev 18:0318:03, 9 December 2021‎ DG Regio talk contribs‎ 19,338 bytes +2,944‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

4 December 2021

• curprev 16:1716:17, 4 December 2021‎ DG Regio talk contribs‎ 16,394 bytes +3,096‎ ‎Changed label, description and/or aliases in fr, and other parts: Adding French translations

12 October 2021

• curprev 23:2223:22, 12 October 2021‎ DG Regio talk contribs‎ 13,298 bytes +2,649‎ ‎Created claim: summary (P836): This project aims to give continuity to the policy on the development of generic medicinal products intended for the treatment of pathologies with high socio-economic impact, and proposes the development of a new generic specialty of bilastine, 20 mg tablets, for the treatment of allergic rhinoconjunctivitis and hives._x000D_ Currently no generic bilastin is registered on the Spanish market and the planned development must demonstrate its bioequ...
• curprev 23:2223:22, 12 October 2021‎ DG Regio talk contribs‎ 10,649 bytes −2,649‎ ‎Removed claim: summary (P836): This project aims to give continuity to the policy on the development of generic medicinal products intended for the treatment of pathologies with high socio-economic impact, and proposes the development of a new generic specialty of bilastine, 20 mg tablets, for the treatment of allergic rhinoconjunctivitis and hives._x000D_ Currently no generic bilastin is registered on the Spanish market and the planned development must demonstrate its bioe...
• curprev 23:0423:04, 12 October 2021‎ DG Regio talk contribs‎ 13,298 bytes +183‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 23:0423:04, 12 October 2021‎ DG Regio talk contribs‎ 13,115 bytes +2,649‎ ‎Created claim: summary (P836): This project aims to give continuity to the policy on the development of generic medicinal products intended for the treatment of pathologies with high socio-economic impact, and proposes the development of a new generic specialty of bilastine, 20 mg tablets, for the treatment of allergic rhinoconjunctivitis and hives._x000D_ Currently no generic bilastin is registered on the Spanish market and the planned development must demonstrate its bioequ...

11 October 2021

• curprev 15:1215:12, 11 October 2021‎ DG Regio talk contribs‎ 10,466 bytes +427‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates

10 October 2021

• curprev 10:3210:32, 10 October 2021‎ DG Regio talk contribs‎ 10,039 bytes +499‎ ‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location

8 October 2021

• curprev 14:1514:15, 8 October 2021‎ DG Regio talk contribs‎ 9,540 bytes −10‎ ‎Changed label, description and/or aliases in en
• curprev 14:1514:15, 8 October 2021‎ DG Regio talk contribs‎ 9,550 bytes +9,550‎ ‎Created a new Item